ROSIVER 1 % — DIN 02440342
IVERMECTIN : 1 % · GALDERMA CANADA INC · CREAM · wholesale supply in Canada
Health Canada status: MARKETED
What is ROSIVER?
ROSIVER 1 % contains IVERMECTIN : 1 %. It is listed in the Health Canada Drug Product Database under DIN 02440342, held by GALDERMA CANADA INC, supplied as CREAM for TOPICAL administration. Health Canada currently lists it as marketed, status dated 25-May-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ROSIVER used for?
Topical treatment of inflammatory lesions (papules and pustules) of rosacea in adults 18 years of age or older.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Ivermectin cost around the world?
Ivermectin is listed on 12 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Iceland | max wholesale | 9 | 13 | ISK███.██ |
| United States | acquisition | 4 | 11 | USD███.██ |
| Australia | ex-manufacturer | 2 | 4 | AUD███.██ |
| Austria | KVP (Kassenverkaufspreis) | 3 | 3 | EUR███.██ |
| Luxembourg | reimbursement | 3 | 3 | EUR███.██ |
| United Arab Emirates | public | 1 | 2 | AED███.██ |
| Bahrain | retail (max) | 1 | 2 | BHD███.██ |
| Greece | producer price (ex-factory) | 2 | 2 | EUR███.██ |
| South Africa | single exit price | 2 | 2 | ZAR███.██ |
| Czechia | max producer price (ex-factory) | 1 | 1 | CZK███.██ |
| Romania | max producer price | 1 | 1 | RON███.██ |
| Saudi Arabia | public | 1 | 1 | SAR███.██ |
45 pack listings across 30 brand entries and 11 price bases, refreshed 08 Sep 2026. Ranges span every Ivermectin pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Ivermectin in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
2 holders have a Canadian DIN containing Ivermectin, across 2 DINs, of which 2 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| GALDERMA CANADA INC | 1 | 1 | ROSIVER | Sourceable in Canada |
| PHARMASCIENCE INC | 1 | 1 | PMS-IVERMECTIN | Sourceable in Canada |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 1 % |
|---|---|
| Dosage form | CREAM |
| Route | TOPICAL |
| Pack configuration (monograph) | 15 g, 30 g, 45 g and 60 g laminated tubes with a child-resistant cap. Physician samples in 2 g laminate tubes. |
| Storage | Store at room temperature (15°C to 25°C). |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Ivermectin |
|---|---|
| ATC code | D11AX22 |
| AHFS class | 84:04.12 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02440342 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2440342 |
| Brand name | ROSIVER |
| Generic / active ingredient | IVERMECTIN : 1 % |
| Market authorization holder | GALDERMA CANADA INC |
| Health Canada schedule | Prescription |
| ATC code | D11AX22 |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D11AX |
| Current status | MARKETED |
| Status date | 25-May-2015 |
| Original market date | 2015-05-25 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Apply once daily at bedtime. Use a pea-size amount for each of the five areas of the face (forehead, chin, nose, each cheek). Spread as a thin layer, avoiding eyes and lips. Wash hands after use.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to ivermectin or to any ingredient in the formulation or component of the container.
Warnings and precautions
May cause aggravation of rosacea; discontinue if severe. Contains cetyl/stearyl alcohol, parabens, and propylene glycol which may cause skin reactions or irritation. Avoid eyes and lips.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
2 of 2 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| PMS-IVERMECTIN | 1 % | CREAM | PHARMASCIENCE INC | MARKETED | 02557363 |
2 · Same class — other molecules in ATC D11AX
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Pyrithione Zinc | 2 IN 1 ANTI-DANDRUFF SHAMPOO AND CONDITIONER · 2 IN 1 CONDITIONING DANDRUFF SHAMPOO · 2 IN 1 CONDITIONING DANDRUFF TREATMENT SHAMPOO · 2 IN 1 DANDRUFF RELIEF SHAMPOO & CONDITIONER · +343 more | 363 | 67 | Yes |
| Finasteride | AURO-FINASTERIDE 1MG · FINASTERIDE · JAMP FINASTERIDE TABLETS · MINT-FINASTERIDE · +5 more | 10 | 8 | Yes |
| Minoxidil, Topical | APO-GAIN LIQ 20MG/ML · GEN-MINOXIDIL LIQ 2% · HAIR REGROWTH FORMULA · HAIR REGROWTH TREATMENT · +11 more | 16 | 7 | Yes |
| Ivermectin | PMS-IVERMECTIN · ROSIVER | 2 | 2 | Yes |
| Hydroquinone | ACTIVE 4 · AFRICAN GOLD SKIN DISCOLORATION FADE CRM 2% · AMBI EXTRA SKIN DISCOLORATION FADE CREAM · BANISHING CREAM · +63 more | 67 | 1 | Yes |
| Brimonidine | ONRELTEA | 1 | 1 | Yes |
| Eflornithine | VANIQA | 1 | 1 | Yes |
| Deoxycholic Acid | BELKYRA | 1 | 1 | Yes |
| Other Dermatologicals | DERMAGRAN II OINTMENT-ONT TOP 0.25% · SHUR-CLENS SOLN 20% · WITCH HAZEL | 3 | 0 | Not in Canada |
| Monobenzone | BENOQUIN CRM 20% | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC D11A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| D11AH | Abrocitinib · Alitretinoin · Crisaborole · Delgocitinib · Dupilumab · +5 more | 25 | 19 |
| D11AF | Wart And Anti-Corn Preparations | 33 | 1 |
| D11AA | Antihidrotics | 397 | 0 |
| D11AC | Cetrimide · Medicated Shampoos · Others · Povidone-Iodine · Selenium Compounds · +1 more | 27 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is ROSIVER called?
The same molecule, Ivermectin, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Soolantra | Latin | Bahrain, Czechia, Iceland, South Africa |
| Noromectin | Latin | Iceland |
| Stromectol | Latin | Australia, Iceland |
| Bimectin Horse Oral Paste | Latin | Iceland |
| GLENMECT | Latin | Australia |
| Noromectin Drench | Latin | Iceland |
| Bimectin | Latin | Iceland |
| Eqvalan, vet. | Latin | Iceland |
| Ivermectin Medical Valley | Latin | Iceland |
| Ivomec, vet. | Latin | Iceland |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.